Fair Value Measurements

3 Months Ended

Mar. 31, 2017

Note 2: Fair Value Measurements

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including available-for-sale fixed income securities, trading fixed income and equity securities held in its deferred compensation plan and the liability associated with its deferred compensation plan. There were no transfers between fair value measurement levels during the three months ended March 31, 2017 and April 1, 2016. Any transfers between fair value measurement levels would be recorded on the actual date of the event or change in circumstances that caused the transfer. The fair value of these certain financial assets and liabilities was determined using the following inputs at March 31, 2017:

	Fair Value Measurements at Reporting Date Using
(In thousands)	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)

Assets
Money market
securities ⁽¹⁾	$	13,138	$	13,138	$	-	$	-

Fixed income available-
for-sale securities ⁽²⁾		67,817		-		67,817		-

Fixed income trading
securities held in deferred
compensation plan ⁽³⁾		15,271		15,271		-		-

Equity trading securities
held in deferred
compensation plan ⁽³⁾		37,429		37,429		-		-

Total	$	133,655	$	65,838	$	67,817	$	-

Liabilities
Deferred compensation
plan ⁽⁴⁾		58,320		58,320		-		-

Total	$	58,320	$	58,320	$	-	$	-

	⁽¹⁾	Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet.
	⁽²⁾	Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet.
	⁽³⁾	Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet.
	⁽⁴⁾	Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet.

The fair value of these certain financial assets and liabilities was determined using the following inputs at December 30, 2016:

	Fair Value Measurements at Reporting Date Using
(In thousands)	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)

Assets
Money market
securities ⁽¹⁾	$	21,918	$	21,918	$	-	$	-

Fixed income available-
for-sale securities ⁽²⁾		58,755		-		58,755		-

Fixed income trading
securities held in deferred
compensation plan ⁽³⁾		11,872		11,872		-		-

Equity trading securities
held in deferred
compensation plan ⁽³⁾		36,395		36,395		-		-

Total	$	128,940	$	70,185	$	58,755	$	-

Liabilities
Deferred compensation
plan ⁽⁴⁾		53,617		53,617		-		-

Total	$	53,617	$	53,617	$	-	$	-

	⁽¹⁾	Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet.
	⁽²⁾	Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet.
	⁽³⁾	Included in prepaid expenses and other assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet.
	⁽⁴⁾	Included in accrued payroll and employee benefits and deferred compensation on the Company’s unaudited condensed consolidated balance sheet.

Fixed income available-for-sale securities as of March 31, 2017 and December 30, 2016 represent obligations of United States agencies. Fixed income and equity trading securities represent mutual funds held in the Company’s deferred compensation plan. See Note 6 for additional information about the Company’s deferred compensation plan.

Cash, cash equivalents and short-term investments consisted of the following as of March 31, 2017:

(In thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value

Classified as current assets:
Cash	$	73,948	$	-	$	-	$	73,948

Cash equivalents:
Money market securities		13,138		-		-		13,138
Total cash equivalents		13,138		-		-		13,138
Total cash and cash equivalents		87,086		-		-		87,086

Short-term investments:
U.S. agency securities		68,000		2		(185)		67,817
Total short-term investments		68,000		2		(185)		67,817


Total cash, cash equivalents and short-term investments	$	155,086	$	2	$	(185)	$	154,903

Cash, cash equivalents and short-term investments consisted of the following as of December 30, 2016:

(In thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value

Classified as current assets:
Cash	$	93,049	$	-	$	-	$	93,049

Cash equivalents:
Money market securities		21,918		-		-		21,918
Total cash equivalents		21,918		-		-		21,918
Total cash and cash equivalents		114,967		-		-		114,967

Short-term investments:
U.S. agency securities		59,000		-		(245)		58,755
Total short-term investments		59,000		-		(245)		58,755


Total cash, cash equivalents and short-term investments	$	173,967	$	-	$	(245)	$	173,722

The following table summarizes the cost and estimated fair value of short-term fixed income securities classified as short-term investments based on stated effective maturities as of March 31, 2017:

	Amortized		Estimated
(In thousands)	Cost		Fair Value

Due within one year	$	24,000	$	23,971
Due between one and two years		44,000		43,846
Total	$	68,000	$	67,817

At March 31, 2017 and December 30, 2016, the Company did not have any assets or liabilities valued using significant unobservable inputs.

The following financial instruments are not measured at fair value on the Company's consolidated balance sheet at March 31, 2017 and December 30, 2016, but require disclosure of their fair values: accounts receivable, other assets and accounts payable. The estimated fair value of such instruments at March 31, 2017 and December 30, 2016 approximates their carrying value as reported on the consolidated balance sheet.

There were no other-than-temporary impairments or credit losses related to available-for-sale securities during the three months ended March 31, 2017 and April 1, 2016.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details